| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |